Common environmental stressors faced by insects include variation in oxygen availability, temperature and moisture[@b1][@b2]. For example, insects living at high altitudes or under ice will experience low temperatures and hypoxic (low oxygen) conditions[@b3][@b4], while those living underground or in dung pats may experience hypoxic and/or hypercapnic (high carbon dioxide) conditions[@b5]. Similarly, some life-stages of insects (e.g. holometabolous larvae) may routinely experience hypoxic or anoxic conditions during development[@b6]. For most ectotherms, including many insects, fitness is reduced below optimal temperatures[@b2][@b7]. As temperatures decrease, voluntary movement typically becomes suppressed one to several degrees before reaching their critical thermal minimum (CT~min~), defined as the loss of co-ordinated movement[@b8][@b9]. The CT~min~ is the lowest limit of activity and therefore represents a functional, though not necessarily lethal, limit. At temperatures below CT~min~, insects enter an inactive coma like state, characterised by the absence of neurological activity (see e.g.[@b10]; review of mechanisms[@b9]; review of terminology and behavioural states[@b8]).

The proposed mechanisms underlying insect chill coma can be grouped into three main categories: i) whole-organism oxygen limitation, ii) signal transmission failure and iii) disruption of ion regulation[@b9]. Whole-organism oxygen limitation is based upon the hypothesis of oxygen- and capacity-limited thermal tolerance (OCLTT)[@b11], which posits that oxygen limitation is the primary factor determining thermal tolerance (i.e. imposing a system-level constraint). According to the OCLTT hypothesis, once aerobic capacity has been exhausted at temperatures approaching the critical thermal limits, anaerobic mitochondrial metabolism begins and anaerobic by-products accumulate. This hypothesis was developed on data from marine animals, and its broader applicability to insects and other arthropods remains contentious and in urgent need of further research[@b12][@b13][@b14][@b15][@b16]. Aside from the proposed direct mechanisms of OCLTT, low oxygen availability may cause indirect stress as insects likely keep their spiracles open for longer to meet their constant cellular oxygen demands[@b17], which in turn may result in elevated respiratory water loss rates[@b18][@b19][@b20]. Increasing metabolic rate - or sustained opening of the spiracles at a given ambient oxygen concentration - may also result in oxidative damage, assuming that cellular respiration rates remain constant. These indirect changes can in turn affect CT~min~ and low temperature tolerance by influencing osmotic balance and, consequently, ion homeostasis and nerve transmission[@b10]. In addition, anoxia may affect the plasticity of cold tolerance in various Diptera species. Rapid cold hardening (RCH) is a form of phenotypic plasticity whereby a non-lethal cold "shock" increases the insects' chill tolerance[@b21]. While anoxia was able to elicit RCH in the house fly *Musca domestica*[@b22], it blocked RCH responses in the flesh fly *Sarcophaga crassipalpis* and *Drosophila melanogaster*[@b23][@b24]. It is therefore clear that the partial pressure of oxygen (P~O2~) may interact with low temperature stress responses - affecting both benign and inducible forms of several traits associated with cold stress resistance - in at least some terrestrial insect species.

The biochemical mechanisms underlying oxygen and low temperature effects for insects, and especially the interactions there of, have not been well explored to date[@b25][@b26][@b27]. Since whole-animal metabolic rate is likely to be affected by both the aforementioned stressors, and may also determine the influence of these stressors, a metabolomics approach can provide insight into changes in metabolic pathways that may underlie oxygen and temperature stress responses. Previous research has shown the potential value of metabolomic profiling for investigating RCH or acclimation responses and cold shock. Such studies have yielded insights into the dynamic changes associated with cold tolerance by providing correlations between temperature tolerance or rates of recovery from chilling, and specific metabolites and key biochemical energy pathways[@b28][@b29][@b30][@b31]. Upregulation of anaerobic metabolites at low temperatures could explain some of the oxygen-temperature interactions, yet a comprehensive suite of metabolites have not been investigated at low temperatures under varying experimental oxygen levels[@b15] (for anaerobic metabolism under hypoxia and heat stress, see)[@b14]. MacMillan *et al.*[@b32] targeted some anaerobic metabolites, including alanine, and found no evidence of cold-induced anaerobic metabolism in *Gryllus pennsylvanicus*, while Michaud *et al.*[@b33] found increased concentrations of alanine, glycerol and succinate in *Belgica antarctica* exposed to −10 °C, suggesting a switch to anaerobic metabolic pathways. However, there is little consensus on the mechanisms at play during cold and hypoxia stressors. The role of OCLTT in setting low temperature limits in terrestrial insects has not been well examined to date as most studies have focused on high temperature responses, and then typically only examined whole-animal metabolic rates (e.g.[@b34][@b35], but see[@b13][@b32]). Results from the beetle *Tenebrio molitor* or cricket *Gryllus pennsylvanicus*[@b13][@b32] suggest that CT~min~ is unlikely to be oxygen limited. However, with only these two studies available covering two distinct taxa, further research is essential, especially given the fundamental importance of this question.

To investigate the hypothesis that whole-animal oxygen limitation may set low temperature tolerance of insects we systematically investigated the influence of oxygen availability on several lethal and non-lethal metrics of low temperature tolerance. Here we make use of final instar larvae of a chill susceptible[@b36] insect pest (false codling moth *Thaumatotibia leucotreta* (Meyrick) (Lepidoptera, Tortricidae)). Although the supercooling point (SCP) is not necessarily a useful measure of low temperature tolerance as its association with mortality depends on the species' freeze tolerance strategy, in *T. leucotreta* larval SCP is equivalent to mortality temperatures[@b36]. Larvae of *T. leucotreta* are chill-susceptible with a CT~min~ of *c*. 6.7 °C when fed and a SCP of *c*. −15.6 °C under standard, benign laboratory rearing conditions[@b36].

We determined the cold stress responses which are more frequently the focus of investigation in such studies by using thermolimit respirometry[@b37] to determine CT~min~ under different controlled P~O2~. We estimated the critical oxygen partial pressure (P~crit~) for maintenance of whole-animal metabolic rate, and investigated changes in metabolites before, during and after chill coma. If chill coma endpoints are driven by oxygen availability, one major expectation is that hypoxia will increase CT~min~ (=less cold tolerant) while hyperoxia (increased oxygen) would decrease CT~min~ (=more cold tolerant)[@b13][@b15] -- relative to normoxia. We also measured SCP under different P~O2~ to assess if oxygen availability could influence this lethal estimate of low temperature tolerance. One prediction that can be made is that SCP would decrease under hypoxia if increased respiratory water loss, and the subsequent decrease in body water content, caused an increased concentration of solutes including cryoprotective molecules, while hyperoxia would be expected to have the opposite effect. In addition, OCLTT hypothesis predicts that if oxygen limitation is a primary driver of this functional low temperature performance limit, anaerobic metabolites should accumulate prior to CT~min~ under normoxia and hypoxia, but this effect should be relieved during hyperoxia. To examine this, 43 metabolites were measured across our suite of experimental conditions to test whether *T. leucotreta* likely employ anaerobic metabolism with the expectation that typical anaerobic metabolites such as lactic acid and alanine should be upregulated after hypoxic and potentially also low temperature exposures, but not hyperoxia. Furthermore, we predicted stronger anaerobic metabolite responses below, rather than above, P~crit~ levels, with associated concomitant changes in low temperature tolerance more pronounced under conditions further from homeostasis setpoints.

Results
=======

Critical thermal minimum
------------------------

Thermolimit respirometry (TLR)[@b37] was used to determine critical thermal minima (CT~min~)[@b13] under six different controlled P~O2~ conditions (2.5, 5, 10, 21, 40 kPa O~2~). Using a flow-through respirometry setup, individual larvae were cooled from 15 °C to −15 °C at a cooling rate of 0.25 °C min^−1^. The rate of CO~2~ release (CO~2~) and activity data were analysed to determine CT~min~ (referred to as CO~2~ CT~min~ and activity CT~min~ respectively) following methods outlined in Klok *et al.*[@b12] and Stevens *et al.*[@b13]. CO~2~ CT~min~ and activity CT~min~ were not significantly different from one another (n = 12 vs. n = 9; *Z* = 0.57, *P* = 0.57). The CT~min~ scored visually by an observer in a previous study[@b36] was not significantly different from CO~2~ CT~min~ at 21 kPa O~2~ (n = 19 vs. n = 12; *Z* = 1.68, *P* = 0.09), but was different from activity CT~min~ (n = 19 vs. n = 9; *Z* = 3.25, *P* = 0.001) ([Table 1](#t1){ref-type="table"}). P~O2~ had no effect on CO~2~ CT~min~ nor activity CT~min~, although activity CT~min~ could not be detected at 0 kPa O~2~ (*F*~5,56~ = 0.87, *P* = 0.51 and *H*~4,37~ = 3.48, *P* = 0.48; [Table 1](#t1){ref-type="table"}). Additional TLR parameters commonly measured are presented in online [Supplementary materials](#S1){ref-type="supplementary-material"} ([Table S1](#S1){ref-type="supplementary-material"}).

Supercooling point
------------------

Supercooling points (SCP) under the six different P~O2~ were determined following a modified version of Boardman *et al.*[@b36]. SCP, which is lethal for *T. leucotreta*, was not affected by changes in P~O2~ (*F*~4,216~ = 0.65, *P* = 0.63, mass covariate = 39.29 mg, [Fig. S1A](#S1){ref-type="supplementary-material"}), and start mass had a larger effect on SCP than P~O2~ (*P* = 0.01 vs. *P* = 0.63).

Critical oxygen partial pressure and spiracle activity
------------------------------------------------------

Multiplexed respirometry was used to determine the critical oxygen partial pressure (P~crit~) following Basson and Terblanche[@b38] (further details[@b39]). Metabolic rate (CO~2~) was determined for fourteen larvae at six experimental oxygen concentrations (2.5, 5, 10, 21, 40 kPa O~2~). P~crit~ was determined to be 4.5 kPa ([Fig. 1A](#f1){ref-type="fig"}, full details on methodology in [Supplementary materials](#S1){ref-type="supplementary-material"}). To better understand if active ventilation augmented gas exchange at rest, we estimated the degree of spiracle activity by calculating the coefficient of variation of CO~2~ (COV)[@b40]. P~O2~ influenced spiracle behaviour as evidenced by CO~2~ respirometry traces ([Fig. S2](#S1){ref-type="supplementary-material"}). Under normoxia (21 kPa), as the temperature decreased, metabolic rate and spiracle activity gradually decreased until spiracle activity ceased at CO~2~ CT~min~ ([Fig. S2B](#S1){ref-type="supplementary-material"}). As P~O2~ decreased, gas exchange patterns changed, spiracles remained open for longer periods and COV decreased ([Fig. 1B](#f1){ref-type="fig"}, Friedman ANOVA: Χ^2^ = 39.14, df = 1, *P* \< 0.0001; regression: r = 0.55, *P* \< 0.00001).

Metabolomic profiling
---------------------

In order to investigate the metabolic changes in *T. leucotreta* larvae under the different gas conditions and at different timepoints surrounding chill coma, we measured changes in metabolites following Koštál *et al.*[@b41]. Samples for metabolomics were obtained by repeating the thermolimit respirometry (TLR) experiment with minor modifications under each of the six gas conditions. The modifications were that after the initial 15 °C for 30 min ("before chill coma") and cooling to −2 °C at a ramp rate of 0.25 °C min^−1^, insects were held at −2 °C for 30 min ("during chill coma"). Thereafter, insects were immediately returned to 15 °C and allowed 2 h to recover ("after chill coma"). The forty-three metabolites detected in *T. leucotreta* included 26 amino acids and peptides, 7 tricarboxylic (TCA) cycle metabolites, 9 other organic acids and a biogenic amine ([Table 2](#t2){ref-type="table"}). There were clear effects of both temperature and oxygen, as well as significant interaction effects between temperature and oxygen, on the concentration of most metabolites in *T. leucotreta* ([Table S2](#S1){ref-type="supplementary-material"}, [Fig. 2](#f2){ref-type="fig"}). As we wanted to identify metabolite changes that were attributed to the effects of chill coma ("low temperature effects") and to the oxygen levels before, during or after chill coma ("oxygen effects... chill coma"), results are presented in these respective sections below. Additional data exploring the temporal changes during chill coma under each oxygen concentration are presented in the online [supplementary results and Figures](#S1){ref-type="supplementary-material"}.

### Low temperature effects

Several metabolites varied under normoxia (21 kPa O~2~) at different timepoints before, during and after chill coma ([Fig. S4C](#S1){ref-type="supplementary-material"}). As the timepoints overlapped in the Partial-Least Squares Discriminant Analysis (PLS-DA), neither component 1, that contributed 63.2% of the variance) nor component 2 (17.9% variance) could be used to clearly separate them ([Fig. S4C](#S1){ref-type="supplementary-material"}, permutation test, *P* = 0.516). Variance of importance (VIP) scores indicated that component 1 was loaded by 2-ketoglutaric acid, lactic acid and margaric acid ([Fig. S4D](#S1){ref-type="supplementary-material"}). 2-ketoglutaric acid and margaric acid were not significantly different between timepoints ([Table 2](#t2){ref-type="table"}, [Fig. S7](#S1){ref-type="supplementary-material"}, [Fig. S8](#S1){ref-type="supplementary-material"}). Lactic acid was significantly increased relative to the control (=before chill coma) after recovery from chill coma (*P* \< 0.0037, [Table 2](#t2){ref-type="table"}, [Fig. S8](#S1){ref-type="supplementary-material"}).

### Oxygen effects before chill coma

After 30 min at 15 °C, before cooling and undergoing chill coma, the PLS-DA separated the data into two groups (permutation test, *P* = 0.028, [Fig. 2A](#f2){ref-type="fig"}). Anoxia was considerably different from P~O2~ groups \>5 kPa O~2~, with 2.5 kPa samples falling as intermediates. Component 1 contributed 58.5% of the variance and this component was loaded chiefly by 2-ketoglutaric and lactic acids, shown by the VIP scores ([Fig. 2B](#f2){ref-type="fig"}). 2-ketoglutaric acid was highest in normoxia and decreased under altered oxygen ([Fig. 2B](#f2){ref-type="fig"}, [Fig. S7](#S1){ref-type="supplementary-material"}), with significant differences between 21 kPa and 5 kPa O~2~ ([Table S3](#S1){ref-type="supplementary-material"}). Lactic acid was significantly elevated in anoxia ([Table S3](#S1){ref-type="supplementary-material"}, [Fig. 2B](#f2){ref-type="fig"}, [Fig. S8](#S1){ref-type="supplementary-material"}). Other metabolites that showed a positive correlation with oxygen levels include serine, glutamine, histidine and pyruvic acid; while increases in lactic, maleic, malic, succinic and fumaric acids were correlated with a decrease in oxygen availability ([Fig. 2C](#f2){ref-type="fig"}).

### Oxygen effects during chill coma

After 2 h in chill coma at 0 °C, the data could be separated by PLS-DA into 3 groups: anoxia, 2.5 kPa O~2~ and then the rest of the oxygen treatments ([Fig. 2D](#f2){ref-type="fig"}, permutation test, *P* \< 0.001). As in the earlier results from "oxygen effects before chill coma", changes in 2-ketoglutaric and lactic acids were the driving forces behind component 1 (47.7%) that separated the three groups, together with glutamine, malic acid, citric acid and alanine ([Fig. 2E](#f2){ref-type="fig"}, [Fig. S5](#S1){ref-type="supplementary-material"}, [Fig. S7](#S1){ref-type="supplementary-material"}). Increases in palmitic, stearic, linoleic and oleic fatty acids and glutamine were all positively correlated with oxygen levels; increases in lactic, fumaric, maleic and malic acids were negatively correlated with oxygen availability during chill coma ([Fig. 2F](#f2){ref-type="fig"}, Figs S5--S8).

### Oxygen effects after chill coma

After 2 h recovery from chill coma, the oxygen treatments all clustered together ([Fig. 2G](#f2){ref-type="fig"}, permutation test, *P* = 0.132). 2-ketoglutaric acid remained the main contributor to component 1 (60.1%), followed by proline, histidine and citric acid. 2-ketoglutaric acid, proline and histidine were reduced under hypoxia, while citric acid was elevated under hypoxia ([Fig. 2H](#f2){ref-type="fig"}, [Fig. S5](#S1){ref-type="supplementary-material"}, [Fig. S7](#S1){ref-type="supplementary-material"}). After recovery, palmitic, oleic and linoleic fatty acids all increased with an increase in oxygen; while levels of maleic, fumaric and malic acids, together with 3-alanine were negatively correlated with oxygen availability ([Fig. 2I](#f2){ref-type="fig"}, Figs S5--S8).

### Pathway analysis

Pathway analyses on data from before chill coma and after chill coma were not significant after adjusting for multiple testing. Seven metabolic pathways (matched to known *Drosophila melanogaster* pathways) were significantly altered by oxygen availability during chill coma (Holm's adjusted *P* \< 0.05, [Table 3](#t3){ref-type="table"}). Significant pathways with high impact (i.e. changes occurring in more important nodes in the network will have a higher impact on the pathway) included three amino acid pathways (glycine, serine and threonine metabolism, arginine and proline metabolism and cysteine and methionine metabolism), glutathione metabolism and aminoacyl-tRNA biosynthesis (a key component in translation). Nitrogen metabolism and cyanoamino acid metabolism were also significantly enriched, but had zero impact, indicating that the changes occurred in marginal or relatively isolated positions in the pathway.

Discussion
==========

Three results of these experiments are most significant. First, we show here that *T. leucotreta* larvae are likely not oxygen limited at low temperatures or during chill coma, as exposure to different P~O2~ levels does not influence their low temperature tolerance scored as either activity limits (CT~min~) or lethal (SCP) limits. This result is largely in keeping with the handful of other studies of tracheate arthropods that have investigated low temperature responses under altered oxygen levels[@b13][@b32]. Furthermore, *T. leucotreta* appears capable of extracting sufficient oxygen to sustain aerobic metabolism from acutely hypoxic environments through careful regulation of their spiracles, excretory water loss and, by association, likely also ion regulation mechanisms. Finally, *T. leucotreta* clearly have some scope for anaerobic metabolism, which is likely to be of interest for post-harvest control of this pest when attempting to augment low temperature commodity disinfestation with modified atmospheres[@b42][@b43], and may contribute to their ability to survive in fruits in which they routinely experience hypoxic and/or hypercapnic microenvironments. For example, internal oxygen concentrations of down to 1% have been documented in 'Hass' avocado fruit[@b44], a known host of *T. leucotreta*[@b45].

Responses of animals to hypoxia can be broadly classified as either the regulating class or the conforming class[@b46][@b47]. While the regulating class increases glycolytic flux in order to maintain normal processes during hypoxia, those in the conforming class decrease respiration rate, energy and substrate usage. Species that fall into the regulating class are typically able to maintain damage repair processes during hypoxia, but organisms in the conforming class will only start repair processes upon return to normoxia and usually survive long-term low oxygen exposures better than those in the regulating class. As P~O2~ decreases, typically at values close to P~crit~, animals switch from being oxy-regulators to being oxy-conformers[@b48][@b49]. *Thaumatotibia leucotreta* larvae likely follow this pattern, regulating normal processes above P~crit~, and switching to be oxy-conformers below P~crit~. The results of the metabolite profiling here further support this notion given that *T. leucotreta* larvae possess at least some ability to generate anaerobic metabolism end-products. This scope for anaerobic metabolism may be typical for larvae of holometabolous insects that routinely experience hypoxic conditions in artificial rearing mediums, necrotic fruit, or while wandering underground to pupate[@b6].

We estimated P~crit~ of *T. leucotreta* to be *c*. 4.5 kPa, similar to other Lepidopteran larvae[@b50][@b51], since this was the level at which metabolism was maintained before suppression at lower P~O2~ levels[@b52]. However, P~crit~ is notoriously variable, depending on a suite of methodological factors[@b38][@b53][@b54] and on which metabolic parameter (resting or minimum) is employed, and this was evident in our results too (e.g. P~crit~ ranged from 1.25 to 6 kPa O~2~ at 15 °C). One curious result, suggesting that larvae actively enhance gas exchange at rest under even lower levels of P~O2~, is that at 2.5 kPa, a value much lower than our estimated P~crit~, larvae likely employed active gas exchange to boost metabolism, or perhaps may be reflective of a second critical P~O2~ value showing the onset of anaerobic metabolism reported for marine organisms[@b49] ([Table S1](#S1){ref-type="supplementary-material"}). Such increases in CO~2~ under hypoxia have also been documented in *Drosophila* at 3 kPa[@b55] and scarabaeid beetles[@b56] and has been attributed to either the stimulation of escape behaviour or an increase in tracheal conductance by increased ventilation or tidal volume (i.e. a switch to more convective gas exchange; see discussions in[@b40][@b56][@b57]). As activity CT~min~ at 2.5 kPa O~2~ are not significantly different to that estimated at 21 kPa O~2~, the nature of this increase in metabolic rate under hypoxia likely reflects a change in mode or pattern of gas exchange (see also [Fig. S2](#S1){ref-type="supplementary-material"}).

Under hypoxia, insects typically modify spiracle behaviour (e.g. opening/closing frequency, duration) in order to maintain cellular respiration, for example by keeping their spiracles open for longer to ensure sufficient oxygen supply to metabolically-active tissues[@b17][@b58]. However, this may result in elevated respiratory water loss rates[@b18][@b19][@b20], cellular oxidative damage[@b17], and perturbation of haemolymph pH balance[@b59]. Under normoxia, *T. leucotreta* larvae actively excrete water (likely from their mid-gut, rather than intracellular fluid) in preparation for lower temperatures[@b36][@b39]. Regulation of water may partly explain why larvae appear to limit the number of excretion events during chilling exposure under hypoxia, but not other P~O2~ levels ([Fig. S3](#S1){ref-type="supplementary-material"}). Regulation of excretion events may reflect a specific adaptation to remove potential ice nucleators from the gut[@b60] or to control ion homeostasis and indirectly regulate low temperature freezing damage and facilitate rapid chilling recovery[@b61]. However, regulation of water flux at the whole-animal level is likely not a priority at values \>P~crit~, but may be important near P~crit~ where a significant reduction in the number of excretion events was observed (Χ^2^ = 3.96, df = 1, *P* = 0.046, additional online results, [Fig. S3](#S1){ref-type="supplementary-material"}). Body water content was not measured before and after cooling under different P~O2~ in this study as previous research has already shown that exposure to hypoxia decreases *T. leucotreta* body water content[@b27].

CT~min~ remained unaffected under the different experimental P~O2~ conditions. These results therefore do not match the general expectation that CT~min~ would increase under hypoxia and decrease during hyperoxia, but is a similar outcome to what has been reported in *Tenebrio molitor* beetles[@b13]. In addition, SCP was unaffected by variation in P~O2~. Therefore, the chill tolerance of *T. leucotreta* larvae are unlikely to be oxygen limited at low temperatures since exposure to P~O2~ did not alter their lower limits to activity (i.e. CT~min~), nor the low temperature body freezing point (SCP). Our hypothesis regarding P~O2~ affecting SCP relied on significant changes in body water content. However, larvae survive up to 10 days without access to food and water[@b39] suggesting considerable desiccation and starvation tolerance, perhaps limiting such a possible outcome under the present experimental conditions.

The metabolomic profiling reported here revealed that 2-ketoglutaric acid was the main metabolite measured in *T. leucotreta* larvae at all timepoints and treatments. This metabolite is an important intermediate in the Krebs cycle, and may also play a role as an antioxidant, much like histidine. Increased histidine has previously been associated with cold tolerance in *Drosophila*[@b31][@b62]. We also found that an increase in histidine was associated with an increase in oxygen availability ([Table S3](#S1){ref-type="supplementary-material"}, [Fig. 2C](#f2){ref-type="fig"}, [Fig. S5](#S1){ref-type="supplementary-material"}), indicating that histidine may be an important antioxidant for scavenging reactive oxygen species (ROS) produced under hyperoxia[@b63]. The decrease in histidine under hypoxia may indicate the utilization of histidine to generate 2-ketoglutarate during oxidative stress, without engaging the tricarboxylic cycle[@b64]. Further evidence for this pathway may be found by the increase in succinic acid during hypoxia ([Table S3](#S1){ref-type="supplementary-material"}, [Fig. S7](#S1){ref-type="supplementary-material"}), as succinate is a by-product of the reaction of 2-ketoglutarate and ROS[@b64]. In summary, these results could indicate that these insects have a hypoxia-induced reactive oxygen species response, likely to modulate hypoxia-inducible factors (HIF) pathways[@b65], and would be a worthwhile avenue for future research.

Metabolomic results from within each oxygen treatment showed that lower temperatures under normoxia or experimentally-decreased oxygen treatments are likely associated with an increased reliance upon anaerobic metabolism, as indicated by elevated lactic acid ([Fig. S8](#S1){ref-type="supplementary-material"}). During hyperoxia, chilling these insects also resulted in increases in alanine, indicating that oxygen availability is likely not the main factor behind the switch to anaerobic metabolism ([Table 2](#t2){ref-type="table"}, [Fig. S5](#S1){ref-type="supplementary-material"}). Another possibility is that mitochondrial function is strongly inhibited during chill coma, thus any effect of oxygen limitation on chill coma may be inconsequential for insects. Our data do however suggest some decoupling between glycolysis (running) and TCA (blocked) at low temperatures, but the cause is not clear. Additional work on tissue-specific metabolite responses would perhaps resolve this.

Within the timepoints measured (before, during, and after chill coma), changes in oxygen availability have diverse effects. Before chill coma (at 15 °C), greater oxygen availability results in higher concentrations of amino acids and pyruvic acid, indicating higher rates of aerobic metabolism. (see [Fig. S2](#S1){ref-type="supplementary-material"}). During chill coma and after recovery, greater oxygen availability may allow for changes in fatty acid composition, which is likely useful for coping with subsequent temperature stress. Changes in lipid composition have a known association with chill coma recovery[@b66][@b67][@b68], CT~min~[@b69] and have recently been implicated in *T. leucotreta* low temperature tolerance[@b27]. In all cases, increased anaerobic metabolite concentrations with declining oxygen availability (especially lactic acid and alanine) indicates an increased reliance upon anaerobic metabolism, and a build-up of citric acid cycle intermediates indicates that the aerobic pathway is not working efficiently. 3-alanine, which is increased during hypoxia and cold in our study organism, can depress the electrical activity of the nerve chain in insects[@b70] which could thus play a role in the immobility of insects in chill coma and under hypoxia.

The pathway analysis indicates that amino acid metabolism is significantly altered by oxygen availability during chill coma, both at translational and metabolic level ([Table 3](#t3){ref-type="table"}). The pathway with the highest impact was glycine, serine and threonine metabolism, which is overall reduced under hypoxia. Pyruvate generated by this pathway enters the citric acid cycle to produce adenosine triphosphate (ATP). Our data clearly shows a reduction in pyruvic acid under chill coma and all hypoxia treatments ([Fig. S6](#S1){ref-type="supplementary-material"}) showing a lack of pyruvic acid available for aerobic metabolism. In addition, glutathione metabolism pathways are significantly increased during chill coma under hypoxia, leading to a significant increase in glutathione ([Table 2](#t2){ref-type="table"}, [Fig. S6](#S1){ref-type="supplementary-material"}). Glutathione has antioxidant properties and has been well studied in association with cold tolerance in insects[@b71]. Further work from a diverse range of insect taxa is urgently required to address the generality of these results, but consensus thus far suggests insect low temperature tolerance traits are not governed by oxygen limitation despite potential induction of anaerobic metabolic pathways.

Methods
=======

Insects
-------

False codling moth *Thaumatotibia leucotreta* (Lepidoptera: Tortricidae) larvae were obtained from the Cedar Biocontrol Insectary, XSIT (Pty) Ltd, Citrusdal, South Africa and reared at 25 ± 5 °C at 50% relative humidity (L:D 12:12 h), under standard culture conditions (reviewed in Carpenter *et al.*)[@b72]. Final instar larvae were used in all experiments.

Determination of cold tolerance under different oxygen conditions: Thermolimit respirometry
-------------------------------------------------------------------------------------------

Thermolimit respirometry (TLR)[@b37] was used to determine critical thermal minima (CT~min~) under different controlled P~O2~ conditions[@b16]. Different P~O2~ (0, 2.5, 5, 10, 40 kPa O~2~) were obtained from compressed cylinders with balance nitrogen (Air Products, South Africa), while normoxic air (21 kPa O~2~) was generated using an aquarium pump. All air was passed through a set of scrubber columns containing soda lime and 50:50 silica gel:Drierite (WA Hammond Drierite Company Ltd., Ohio, USA) to remove CO~2~ and H~2~O from the airstream. Rate of CO~2~ release (CO~2~) was measured in parts per million (ppm) using a calibrated Li-7000 infra-red gas analyser and data were recorded with standard LiCor software (LiCor, Lincoln, Nebraska, USA) on a desktop PC. Flow rate was maintained at 200 ml min^−1^ (STPD) using a mass flow control valve (Sidetrak, Sierra International, USA) connected to a mass flow control box (Sable Systems, Las Vegas, Nevada, USA) and activity was monitored electronically (AD-2, Sable Systems) in only a subset of individuals due to equipment constraints. Individual larvae were weighed before and after each respirometry run on a microbalance (accuracy ± 0.1 mg; AB104-S/Fact, Mettler Toledo International, Inc.).

Individual larvae were recorded separately in 2 mL cuvettes, and cuvettes were submerged in a programmable circulating and refrigeration bath filled with ethanol (CC410wl, Huber, Germany) set to follow a CT~min~ program: hold at 15 °C for 30 min to allow larvae within respirometry cuvettes to equilibrate with bath temperature; cool down to −15 °C at a ramp rate of 0.25 °C min^−1^. Temperature logging with iButtons (DS1922L, accuracy ± 0.5 °C, Dallas Semiconductors, Dallas, Texas, USA) revealed that the average cooling rate achieved by the bath during TLR recordings was \~0.24 °C min^−1^. This was repeated for n = 8 to 14 larvae for each P~O2~ (0, 2.5, 5, 10, 21, 40 kPa O~2~). No individuals were re-used at another oxygen level.

Supercooling point (SCP) under different oxygen conditions
----------------------------------------------------------

Supercooling points under different P~O2~ were determined following a modified version of Boardman *et al.*[@b36]. Pre-weighed larvae were placed in a 0.5 ml microtube (with air holes) in contact with a thermocouple (T-type, 0.005 m gauge, Omega Engineering, Inc., Stamford, CT). Larvae were placed in an airtight 0.6 L container, plumbed to receive air from either an aquarium pump (21 kPa O~2~), or a pressurised cylinder (0, 2.5, 10, 21, 40 kPa O~2~). The container was submerged in the programmable bath, set to follow the same temperature program as for TLR, except that cooling was continued down to −30 °C. Insect body temperatures were recorded at 1 Hz using a USB TC-08 thermocouple datalogger (Pico Technology, UK) connected to a desktop computer. The SCP was detected as the temperature just prior to the release of latent heat of crystallization[@b73]. A total of n = 32 or n = 48 larvae were analysed under each P~O2~. SCP under 21 kPa O~2~ was repeated with both air directly from the aquarium pump and air scrubbed of CO~2~ and H~2~O (see respirometry setup above) in order to ensure no differences were obtained as a result of the source. Data were pooled as there was no significant difference between the scrubbed or unscrubbed air (t~46~ = −0.003, *P* = 0.99).

Determination of critical oxygen partial pressure (P~crit~)
-----------------------------------------------------------

Multiplexed respirometry was used to determine the critical oxygen partial pressure (P~crit~) following Basson and Terblanche[@b38] (further details[@b39]). The basic respirometry setup was as described above for TLR, with the addition of a multiplexer (Sable Systems, RM8 Intelligent Multiplexer, V5) which allowed for the measurement of 7 individuals per respirometry run with 1 spare baseline channel.

Seven larvae at a time were placed in individual 2 mL cuvettes maintained at 15 °C using the programmable bath (total n = 14). For each P~O2~ treatment, gases were switched manually at the start of a 30 min baseline recording. Thereafter, each cuvette was measured for 30 min at each P~O2~ and the order for five oxygen concentrations (2.5, 5, 10, 21, 40 kPa O~2~) was randomised. In all cases however, the final exposure to 0 kPa O~2~ was performed last as the effects of anoxia on these larvae are unknown and to avoid any potential damaging effects of reperfusion injury[@b38][@b74]. Inactive channels were also flushed at 200 ml min^−1^ (\~29 ml min^−1^ per channel) with the same gas as the active channel. All 14 individuals were therefore recorded at all six P~O2~ conditions. *T. leucotreta* larvae are able to survive at least 10 days at low (10%) relative humidity so the lengthy exposure to dry air was not considered to be problematic[@b39]. Baseline recordings were taken before and after each respirometry run to correct for potential analyser drift which was typically negligible.

Respirometry data extraction and analyses
-----------------------------------------

All respirometry files (TLR and Pcrit experiments) were baseline drift-corrected and CO~2~ was converted to μl h^−1^ using Expedata version 1.8.2 (Sable Systems International).

For TLR, the CO~2~ and activity data were analysed to determine CO~2~ CTmin and activity CTmin following methods similar to Klok *et al.*[@b12] and Lighton and Turner[@b37] and expanded to CT~min~ usage in Stevens *et al.*[@b13]. Using custom-written automated data extraction scripts (macros), CO~2~ data were converted to absolute difference sum (ADS, the cumulative sum of absolute differences between adjacent measurements). The actual inflection point of the ADS was calculated by selecting the period of data around the inflection point, and fitting a linear regression through this selection. The highest residual from this linear regression corresponds to the time at which CO~2~ CT~min~ occurred. CO~2~ CT~min~ (in °C) was calculated using the observed cooling rate of 0.24 °C min^−1^.

Activity CT~min~ was calculated in a similar manner, with the exception that the data for the selection of the infection point was restricted to the portion of the file that corresponded to the end of activity (determined by visual inspection). Activity data were not adequate for determining CT~min~ under anoxic conditions as the gas causes immobility of the larvae within 30 min (i.e. before cooling starts).

Thereafter, average metabolic rate (MetAve) and minimum metabolic rate (MetMin) during cooling (from 15 °C to 0 °C) were calculated. The temperature at which MetMin occurred (TMetMin) was calculated using the observed cooling rate of 0.24 °C min^−1^. In a small handful of files, certain variables were not able to calculated (see sample sizes in [Table S1](#S1){ref-type="supplementary-material"}) and these variables were excluded from analyses.

For P~crit~, the central 20 min from each individual under each P~O2~ was targeted for analysis using custom written macros. In order to reduce the potential effects of activity on influencing P~crit~ estimates, within this central 20 min, the mean of the most level 300 s was extracted to represent "resting metabolic rate" and the mean of the lowest 30 s was extracted to represent "minimum metabolic rate". In order to measure the degree of spiracle activity, the coefficient of variation of CO~2~ (COV) was calculated as the standard deviation divided by the mean CO~2~[@b40] from the central 20 min of each individual, under each P~O2~.

Respirometry data analysis
--------------------------

Data were checked for normality and equal variance, and where these assumptions were violated, non-parametric tests were used. Where body size (i.e. fresh mass) was a significant covariate, an analysis of covariance (ANCOVA) was used with P~O2~ as the categorical variable and body mass as the continuous predictor variable. All statistics were performed using Statistica software (v.12, StatSoft, Inc., Tulsa, OK, USA) unless otherwise mentioned. Overlapping 95% confidence intervals were used to identify homogenous groups.

The CO~2~ CT~min~ and activity CT~min~ were compared to data from Boardman *et al.*[@b36] where CT~min~ was scored visually (referred to as "visual CT~min~") using a non-parametric t-test. The CO~2~ CT~min~ were compared between P~O2~ using an ANCOVA as mass was a significant correlate (r = −0.27, *P* = 0.04). Activity CT~min~, MetAve, MetMin and TMetMin were compared using Kruskall-Wallis ANOVA. Differences in excretion events during cooling were compared using a generalized linear model with a binomial distribution and logit link function. Overall, start mass was significantly correlated with SCP (r = 0.17, *P* = 0.01) therefore an ANCOVA was used to compare the effects of different P~O2~ on SCP.

P~crit~ data can be analysed using a variety of common methods: ordinary least square regression, piece-wise linear regression, non-linear regression, t-tests and one-way repeated measures Friedman ANOVA[@b38][@b53][@b54]. Here, we have used t-tests, ordinary least square regression and a novel method for determining P~crit~ using a boosted regression tree. Firstly, Wilcoxon matched pairs tests were used to compare between close P~O2~ groups (0 and 2.5 kPa, 2.5 and 5 kPa, etc) to identify the area in which the P~crit~ lies. Secondly, an ordinary least-squares regression was fitted to the CO~2~ data from 0, 2.5 and 5 kPa O~2~, and a second regression was fitted to the CO~2~ data from 10, 21 and 40 kPa O~2~. The intercept of the two equations for these regressions was considered P~crit~. Lastly, CO~2~ data were analysed using a boosted regression tree analysis with CO~2~ as the dependent variable and P~O2~ as the continuous variable in Statistica v. 12. The three methods were applied on both resting and minimum metabolic rate data, and generally produced values in close agreement.

Metabolomic profiling
---------------------

In order to investigate the metabolic changes in *T. leucoptreta* larvae under the different gas conditions and at different timepoints surrounding chill coma, we measured the change in metabolites following Koštál *et al.*[@b41]. Samples for profiling were obtained by repeating the thermolimit respirometry (TLR) experiment with minor modifications. Under each of the six gas conditions (0, 2.5, 5, 10, 21, 40 kPa O~2~), a modified CT~min~ program was followed: temperature was held at 15 °C for 30 min ("before chill coma"); cooled down to −2 °C at a ramp rate of 0.25 °C min^−1^ and held at −2 °C for 30 min ("during chill coma") immediately returned to 15 °C and allowed 2 h to recover ("after chill coma"). Samples were obtained at all 3 timepoints. All samples were immediately frozen in liquid nitrogen and stored at −80 °C. Prior to extraction, individuals were thawed and weighed on a microbalance (accuracy ± 0.1 mg; AB104-S/Fact, Mettler Toledo International, Inc.) to determine fresh mass. Individual larvae were homogenised and metabolites were extracted in 70% ethanol[@b41] and refrozen at −80 °C until analysis. Homogenates from four individuals were pooled for each sample. Three samples per oxygen and timepoint were analysed. Despite the potential instability of metabolites during the weighing and extraction process, only largely stable metabolites were included and all comparisons were made between samples within our own study subjected to identical procedures.

The metabolomic profiles were extensively investigated by a combination of GC/MS and liquid chromatography (LC) coupled to MS (LC/MS) in the ethanolic extracts after their treatment with ethyl chloroformate under pyridine catalysis and simultaneous extraction in chloroform[@b41]. The GC/MS acidic metabolite profiles were obtained on a VF-17 capillary column (Agilent, Santa Clara, CA, USA) coupled to a single quadrupole mass spectrometer (ISQ) (Thermo Scientific, San Jose, CA, USA) equipped with an electron impaction ion source and operated in the full-scan mode from 40 to 500 amu. A Trace 1300 gas chromatograph with TriPlus RSH autosampler (both from Thermo Scientific, San Jose, CA, USA), injector and interface holding at 280 °C, was directly coupled to the mass spectrometer via an interface held at 280 °C. An 1 μL aliquot of the chloroform extract was injected in the splitless mode into the GC/MS column. Oven temperature was initially maintained at 45 °C for 1.5 min. Thereafter, it was raised to 330 °C at a rate of 16 °C min^−1^ and maintained for 2 min. Helium was used as the carrier gas and delivered at a constant flow rate of 1.1 mL min^−1^.

LC/MS metabolite profiles were measured after evaporating a 30 μL aliquot of the chloroform extract to dryness by using a mild stream of nitrogen. After dissolution in 100 μL of the LC mobile phase, a 5 μL aliquot was injected into and separated on a Kinetex C18 column (150 × 3 mm; internal diameter \[ID\], 2.6 μm; Phenomenex, Torrance, CA, USA) at 35 °C at a flow rate of 400 μL min^−1^, using a gradient elution with the mobile phase consisting of (A) 5 mM ammonium formate in methanol and (B) 5 mM ammonium formate in water. The gradient elution program was linear from 30% to 100% A for 11 min, then held at 100% A for 1 min, and finally equilibrated for 4 min. The column eluent was directly introduced into a linear quadrupole ion trap mass spectrometer (LTQXL; Thermo Fisher, San Jose, USA) equipped with a HESI II electrospray ionization source operated at 3.5 kV and scanning mass range 150--850 Da.

The data were processed with the Thermo Scientific Xcalibur 2.1 software and an in-house developed Metabolite Mapper platform, which provides automated peak detection and metabolite deconvolution by employing retention time and mass spectral and detector response features, followed by time alignment of the data obtained in each particular analysis for a defined experimental sample set and generation of data matrix, which is automatically exported to a predefined Microsoft Excel™ spreadsheet for further statistical processing. The metabolites were identified against relevant standards and further subjected to quantitative analysis by using an internal standard calibration method. All chemicals used were purchased from Sigma-Aldrich Co. (St. Louis, MO, USA), except the isotope-labeled metabolites used as internal calibration standards, which were obtained from Cambridge Isotope Laboratories (Andover, MA, USA). Whole-body concentrations of the metabolites were recalculated as nmol mg^−1^ using pooled sample mass. While there is a potential bias in scaling the data using fresh mass as body water content may have been altered by the P~O2~ treatments, data were analysed using a more conservative non-parametric GLZ using a normal distribution and identity link function.

Metabolomic data analysis
-------------------------

For each of the 43 metabolites detected, the effects of oxygen and timepoint were analysed independently with a GLZ using a normal distribution and identity link function (SAS 9.3, SAS Institute, Cary, NC, USA). Data were analysed both within timepoint to identify changes due solely to variation in oxygen levels and within an oxygen level to identify changes that are likely due to chill coma. Significance levels were adjusted for false discovery rate correction (FDR) using Benjamini-Hochberg procedure[@b75]. In all cases, FDR-corrected *P*-values were used to determine significance.

Multivariate analysis of whole-system metabolic changes among the oxygen treatments were conducted in MetaboAnalyst 2.0 and 3.0[@b76][@b77] using Partial-Least Squares Discriminant Analysis (PLS-DA) following Colinet *et al.*[@b78]. The significance of the PLS-DA was determined using default permutation tests (1000 permutations, b/w distance separation) in MetaboAnalyst. Variance of importance score (VIP) and pattern finding analyses were used to identify changes in metabolites with VIP scores above 1.5 considered to be significant. Data were scaled using Pareto scaling (mean-centred and divided by the square root of the standard deviation of each variable) and each timepoint were analysed independently. Thereafter, pathway analysis combining pathway enrichment analysis with topology analysis using *Drosophila melanogaster* specific library was conducted on the entire dataset for each timepoint independently to identify enriched metabolic pathways, and the impact of these enrichments. Globaltest pathway enrichment method was used, and the node importance measure was relative betweenness centrality.
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![Critical oxygen partial pressure (P~crit~) (**A**) and coefficient of variation of CO~2~ (COV) (**B**) for *T. leucotreta* larvae was determined under a range of oxygen conditions at 15 °C. All 14 individuals were recorded at all six O~2~ conditions. Raw mean CO~2~ values are shown (A) and were used to calculate P~crit~. The blue and red lines and arrows indicate P~crit~ as estimated from regression tree analysis and linear regressions respectively (see methods for details). Box and whisker plots of the COV data (**B**) show the general trend for a decrease in COV as P~O2~ decreases (regression: r  = 0.55, *P* \< 0.00001).](srep32856-f1){#f1}

![Results of metabolic profiling at each of the three timepoints sampled: before- (top row), during- (middle row) and after (bottom row) chill coma.\
2D score plots (**A**,**D**,**G**) showing the projection of samples onto the first discriminant plane for each of the three timepoints. Each point is a sample (four individuals pooled), colours represent different oxygen treatments (red: 0 kPa O~2~, green: 2.5 kPa O~2~, blue: 5 kPa O~2~, turquoise: 10 kPa O~2~, pink: 21 kPa O~2~, yellow: 40 kPa O~2~) and lines indicate 95% confidence intervals. The variable importance plots (**B**,**E**,**H**), based on VIP scores, shows the top 15 variables that contribute to component 1 at each of the timepoints (based on Pearson correlation). The coloured boxes on the right indicate the relative concentrations of each of the metabolites in each oxygen treatment, with reds indicating highest concentrations and greens the lowest concentrations. Pattern finding analysis (**C**,**F**,**I**) at each timepoint sampled shows the top 25 metabolites that correlated with the increase in oxygen treatments (i.e. from 0 to 40 kPa O~2~). Metabolites in red are positively correlated with the increase in oxygen (i.e. highest concentrations at highest oxygen), while those in blue were negatively correlated (i.e. highest concentrations at lowest oxygen). Note that these results do not necessarily denote significance. Significant differences between oxygen treatments within each timepoint can be found in [Table S3](#S1){ref-type="supplementary-material"}. Refer to [Table S2](#S1){ref-type="supplementary-material"} for compound abbreviations.](srep32856-f2){#f2}

###### Critical thermal minima determined by thermolimit respirometry (TLR) under different P~O2~ conditions.

  O~2~ (kPa)    Visual CT~min~[\*](#t1-fn1){ref-type="fn"} (°C)             Mass (mg)                  CO~2~ CT~min~ (°C)             Activity CT~min~ (°C)
  ------------ ------------------------------------------------- ------------------------------- ------------------------------- -------------------------------
  0                                                                    38.69 ± 7.66(n = 8)             7.33 ± 2.08(n = 8)              Undetectable(n = 4)
  2.5                                                                 50.25 ± 6.88(n = 11)             4.27 ± 0.78(n = 11)             4.54 ± 1.00(n = 9)
  5                                                                    43.53 ± 9.37(n = 8)             3.82 ± 1.64(n = 6)              3.93 ± 1.28(n = 8)
  10                                                                  44.84 ± 9.48(n = 14)             5.03 ± 0.49(n = 14)             7.09 ± 1.48(n = 6)
  21                          6.7  ±  0.1(n = 19)                     40.31 ± 6.70(n = 13)             5.45 ± 0.53(n = 12)             5.10 ± 0.69(n = 9)
  40                                                                  44.99 ± 10.87(n = 12)            4.65 ± 0.72(n = 12)             5.80 ± 1.20(n = 5)
                                                                  **F~4,50~ = 1.04,*P* = 0.40**   **F~5,56~ = 0.87,*P* = 0.51**   **H~4,37~ = 3.48,*P* = 0.48**

Data indicates mean  ±  S.E.M. Statistical results of comparison between oxygen groups are shown in the bottom row. Additional results in [Table S1](#S1){ref-type="supplementary-material"}. CO~2~ CT~min~ and activity CT~min~ were calculated from the inflection point of regressions of the absolute difference sum (ADS) residuals (see methods).

^\*^Critical thermal minimum (CT~min~) data from Boardman *et al.*[@b36].

###### Summary of significant differences between timepoints (Time) within each oxygen treatment (O~2~).

  Group1                                O~2~   0    0    0    2.5   2.5   2.5   5    5    5    10   10   10   21   21   21   40   40   40
  ------------------------------------ ------ ---- ---- ---- ----- ----- ----- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ---- ----
  *Amino acids and peptides*                                                                                                          
   Ala                                                         •     •          \*        \*                                 •    •     
   Arg                                                                          •                                                 •     
   Asn                                              \*   \*          •          •    \*                                      •    •     
   Asp                                                                          \*   •                                                  
   3-Ala                                                            \*          •    •                                                  
   Cys                                              •                                \*                                           •     
   Glu                                                                          •    •                                  \*   •    \*    
   Gln                                         •    •    \*                     •                                            •          
   Gly                                                                          \*   •                                                  
   His                                                                                                                                  
   Ile                                         •    •          •                •    •                                                  
   Leu                                         •    •          •    \*               \*                                           •     
   Lys                                              •         \*    \*                                                                  
   Met                                                                               •                                                  
   Orn                                                              \*     •                                                            
   Phe                                                              \*               \*                                           \*    
   Pro                                                                                                   •                        •    •
   Ser                                                   \*                     \*   •    \*                  \*                        
   Thr                                                                                                                                  
   Trp                                                         •     •               •                                                  
   Tyr                                                                                                                                  
   Val                                                        \*     •          \*   •                                            •     
   2-Aminobutyric acid (2-Aba)                                                  •                                                       
   Cystathionine (CTH)                                                                                                                  
   3,4-Dihydroxyphenylalanine (DOPA)           •    \*         •    \*                                                                  
   Glutathione (GSH)                                          \*     •                                                                  
  *TCA cycle metabolites*                                                                                                             
   Aconitic acid                                               •    \*                                                                  
   2-Ketoglutaric acid (2-KG)                                                                                                           
   Citric acid                                                 •    \*          •                                                       
   Fumaric acid                                               \*          \*                   \*   \*                                  
   Malic acid                                       •    •    \*    \*          \*        \*                                            
   Pyruvic acid                                                                                •    •                                   
   Succinic acid                                               •                                                                  •     
  *Other organic acids*                                                                                                               
   Adipic acid                                                                                                                          
   Lactic acid                                 \*        \*    •           •                                       •                    
   Maleic acid                                                \*          \*                   \*   \*                                  
   Linoleic acid                                                                                                                  \*    
   Linolenic acid                                                                    •                                            •     
   Margaric acid                                                                                                                        
   Oleic acid                                                                                                                     •     
   Palmitic acid                                                                                                                  \*    
   Stearic acid                                                                                                                   \*    
  *Biogenic amine*                                                                                                                    
   Putrescine                                                                   •                        •                              

Time 1 is before chill coma, time 2 is during chill coma and time 3 is after chill coma. Significant effects (*P* \< 0.0037 after false discovery rate correction using the Benjamini-Hochberg procedure[@b75]) are indicated by symbols. The level of significance is indicated by the symbols: blank is *P* \> 0.0037, dot (•) is 0.0037\>*P* \> 0.001, and star (\*) is *P* \< 0.001.

###### Summary of the metabolic pathways that were altered by oxygen availability during chill coma.

  Pathway                                                                           Number of hits (total cmpd)   Hits (KEGG ID)        Hits         *P*-value   Holm adjusted *P*-value    FDR    Impact
  -------------------------------------------------------------------------------- ----------------------------- ---------------- ----------------- ----------- ------------------------- ------- --------
  *Aminoacyl-tRNA biosynthesis* KEGG dme00970 Translation                                     19 (67)                 C00025       L-Glutamic acid     0.000              0.006            0.004   0.138
  C00037                                                                                      Glycine                                                                                             
  C00041                                                                                     L-Alanine                                                                                            
  C00047                                                                                     L-Lysine                                                                                             
  C00049                                                                                  L-Aspartic acid                                                                                         
  C00062                                                                                    L-Arginine                                                                                            
  C00064                                                                                    L-Glutamine                                                                                           
  C00065                                                                                     L-Serine                                                                                             
  C00073                                                                                   L-Methionine                                                                                           
  C00078                                                                                   L-Tryptophan                                                                                           
  C00079                                                                                  L-Phenylalanine                                                                                         
  C00082                                                                                    L-Tyrosine                                                                                            
  C00123                                                                                     L-Leucine                                                                                            
  C00135                                                                                    L-Histidine                                                                                           
  C00148                                                                                     L-Proline                                                                                            
  C00152                                                                                   L-Asparagine                                                                                           
  C00183                                                                                     L-Valine                                                                                             
  C00188                                                                                    L-Threonine                                                                                           
  C00407                                                                                   L-Isoleucine                                                                                           
  *Glutathione metabolism* KEGG dme00480 Metabolism of other amino acids                      5 (26)                  C00025       L-Glutamic acid     0.000              0.012            0.004   0.494
  C00037                                                                                      Glycine                                                                                             
  C00051                                                                                    Glutathione                                                                                           
  C00077                                                                                     Ornithine                                                                                            
  C00134                                                                                    Putrescine                                                                                            
  *Glycine, serine and threonine metabolism* KEGG dme00260 Amino acid metabolism              5 (25)                  C00022        Pyruvic acid       0.000              0.013            0.004   0.571
  C00037                                                                                      Glycine                                                                                             
  C00065                                                                                     L-Serine                                                                                             
  C00188                                                                                    L-Threonine                                                                                           
  C02291                                                                                   L-Cystathione                                                                                          
  *Nitrogen metabolism* KEGG dme00910 Energy metabolism                                        4 (7)                  C00025       L-Glutamic acid     0.001              0.031            0.006   0.000
  C00037                                                                                      Glycine                                                                                             
  C00064                                                                                    L-Glutamine                                                                                           
  C02291                                                                                  L-Cystathionine                                                                                         
  *Cyanoamino acid metabolism* KEGG dme00460 Metabolism of other amino acids                   2 (6)                  C00037           Glycine         0.001              0.035            0.006   0.000
  C00065                                                                                     L-Serine                                                                                             
  *Arginine and proline metabolism* KEGG dme00330 Amino acid metabolism                       8 (37)                  C00025       L-Glutamic acid     0.001              0.035            0.006   0.528
  C00049                                                                                  L-Aspartic acid                                                                                         
  C00062                                                                                    L-Arginine                                                                                            
  C00064                                                                                    L-Glutamine                                                                                           
  C00077                                                                                     Ornithine                                                                                            
  C00122                                                                                   Fumaric acid                                                                                           
  C00134                                                                                    Putrescine                                                                                            
  C00148                                                                                     L-Proline                                                                                            
  *Cysteine and methionine metabolism* KEGG dme00270 Amino acid metabolism                    4 (25)                  C00022        Pyruvic acid       0.001              0.044            0.006   0.227
  C00065                                                                                     L-Serine                                                                                             
  C00073                                                                                   L-Methionine                                                                                           
  C02291                                                                                   L-Cystathione                                                                                          

Raw *P*-values are calculated from the enrichment analysis and significance is based on significant Holm-adjusted *P*-values, and the table is ranked by these values (only significant pathways are shown, *P* \< 0.05). Pathway impact values are calculated from pathway topology analysis and indicate where changes in the metabolites are more likely to have a greater impact on the pathway based on the location of the metabolite within the pathway. FDR - false discovery rate.

[^1]: Present address: Department of Entomology and Nematology, University of Florida, Gainesville, FL 32611, USA.
